- Home
- MCRB vs MAYA Comparison
MCRB vs MAYA Comparison
Compare MCRB & MAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- MAYA
- Stock Information
- Founded
- MCRB 2010
- MAYA 2024
- Country
- MCRB United States
- MAYA United States
- Employees
- MCRB N/A
- MAYA N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- MAYA
- Sector
- MCRB Health Care
- MAYA
- Exchange
- MCRB Nasdaq
- MAYA NYSE
- Market Cap
- MCRB 125.7M
- MAYA 150.3M
- IPO Year
- MCRB 2015
- MAYA 2025
- Fundamental
- Price
- MCRB $13.99
- MAYA $10.15
- Analyst Decision
- MCRB Hold
- MAYA
- Analyst Count
- MCRB 4
- MAYA 0
- Target Price
- MCRB $73.67
- MAYA N/A
- AVG Volume (30 Days)
- MCRB 148.0K
- MAYA 97.0
- Earning Date
- MCRB 08-06-2025
- MAYA 01-01-0001
- Dividend Yield
- MCRB N/A
- MAYA N/A
- EPS Growth
- MCRB N/A
- MAYA N/A
- EPS
- MCRB 8.98
- MAYA N/A
- Revenue
- MCRB N/A
- MAYA N/A
- Revenue This Year
- MCRB N/A
- MAYA N/A
- Revenue Next Year
- MCRB N/A
- MAYA N/A
- P/E Ratio
- MCRB $1.53
- MAYA N/A
- Revenue Growth
- MCRB N/A
- MAYA N/A
- 52 Week Low
- MCRB $6.53
- MAYA $10.03
- 52 Week High
- MCRB $27.40
- MAYA $10.66
- Technical
- Relative Strength Index (RSI)
- MCRB 58.12
- MAYA N/A
- Support Level
- MCRB $12.15
- MAYA N/A
- Resistance Level
- MCRB $15.40
- MAYA N/A
- Average True Range (ATR)
- MCRB 1.36
- MAYA 0.00
- MACD
- MCRB -0.12
- MAYA 0.00
- Stochastic Oscillator
- MCRB 65.29
- MAYA 0.00
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About MAYA MAYWOOD ACQUISITION CORP
Maywood Acquisition Corp is a blank check company.